Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Popat

Showing results (11-20 of 272) with videos related to

Pageof 28
Sort By:
Clinical Lung Cancer|April 6, 2017
Ablative Therapy for Oligometastatic Non-Small Cell Lung CancerOscar Juan, Sanjay Popat
Anti-Cancer Drugs|March 5, 2005
Chemotherapy strategies in the treatment of small cell lung cancerSanjay Popat, Mary O'Brien
Journal of Thoracic Disease|April 2, 2014
Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLCFiona McDonald, Sanjay Popat
Therapeutic Advances in Respiratory Disease|March 25, 2015
The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancerAlexandra Pender, Sanjay Popat
Cancer Treatment Reviews|August 16, 2021
Pleural mesothelioma (PM) - The status of systemic therapyWanyuan Cui, Sanjay Popat
Lung Cancer (Amsterdam, Netherlands)|November 20, 2016
Crizotinib for ROS1 patients: One small step in biomarker testing, one giant leap for advanced NSCLC patientsOscar Juan, Sanjay Popat
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2023
Sitravatinib and Acquired Immune Checkpoint Inhibitor Resistance: A Gem for the Future?Anna Minchom, Sanjay Popat
European Journal of Cancer (Oxford, England : 1990)|August 30, 2005
A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosisSanjay Popat, Richard S Houlston
Journal of the National Cancer Institute|December 22, 2005
Re: Reporting recommendations for tumor marker prognostic studies (REMARK)Sanjay Popat, Richard S Houlston
Pharmacogenomics and Personalized Medicine|October 4, 2014
Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancerTimothy A Yap, Sanjay Popat
Pageof 28

Showing results (11-20 of 272) with videos related to

Sort By:
Pageof 28
Clinical Lung Cancer|April 6, 2017
Ablative Therapy for Oligometastatic Non-Small Cell Lung CancerOscar Juan, Sanjay Popat
Anti-Cancer Drugs|March 5, 2005
Chemotherapy strategies in the treatment of small cell lung cancerSanjay Popat, Mary O'Brien
Journal of Thoracic Disease|April 2, 2014
Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLCFiona McDonald, Sanjay Popat
Therapeutic Advances in Respiratory Disease|March 25, 2015
The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancerAlexandra Pender, Sanjay Popat
Cancer Treatment Reviews|August 16, 2021
Pleural mesothelioma (PM) - The status of systemic therapyWanyuan Cui, Sanjay Popat
Lung Cancer (Amsterdam, Netherlands)|November 20, 2016
Crizotinib for ROS1 patients: One small step in biomarker testing, one giant leap for advanced NSCLC patientsOscar Juan, Sanjay Popat
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2023
Sitravatinib and Acquired Immune Checkpoint Inhibitor Resistance: A Gem for the Future?Anna Minchom, Sanjay Popat
European Journal of Cancer (Oxford, England : 1990)|August 30, 2005
A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosisSanjay Popat, Richard S Houlston
Journal of the National Cancer Institute|December 22, 2005
Re: Reporting recommendations for tumor marker prognostic studies (REMARK)Sanjay Popat, Richard S Houlston
Pharmacogenomics and Personalized Medicine|October 4, 2014
Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancerTimothy A Yap, Sanjay Popat
Pageof 28